These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106 [TBL] [Abstract][Full Text] [Related]
4. HGF/c-Met related activation of β-catenin in hepatoblastoma. Purcell R; Childs M; Maibach R; Miles C; Turner C; Zimmermann A; Sullivan M J Exp Clin Cancer Res; 2011 Oct; 30(1):96. PubMed ID: 21992464 [TBL] [Abstract][Full Text] [Related]
5. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641 [TBL] [Abstract][Full Text] [Related]
6. ACLY-β-catenin axis modulates hepatoblastoma cell proliferation. Lin Y; Fang H; Ma C; Zhou J; Ding M; Sun H; Xu Y; Shan Y; Gao H; Yang L; Gu S; Li H Biochem Biophys Res Commun; 2023 Jun; 663():104-112. PubMed ID: 37121120 [TBL] [Abstract][Full Text] [Related]
7. Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma. Beck A; Eberherr C; Hagemann M; Cairo S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R Cancer Biol Ther; 2016 Nov; 17(11):1168-1176. PubMed ID: 27635950 [TBL] [Abstract][Full Text] [Related]
8. Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma. Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161 [TBL] [Abstract][Full Text] [Related]
9. SOX7 modulates the progression of hepatoblastoma through the regulation of Wnt/β-catenin signaling pathway. Ge J; Zheng Q; Qu H; Zhao Z; Xu Y; Wang H; Gao H; Zhan J J Cancer Res Ther; 2022 Apr; 18(2):370-377. PubMed ID: 35645102 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of cIAP1 in the effective suppression of chemotherapy‑resistant hepatoblastoma. Tsukada R; Nomura M; Ueno T; Okuyama H Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35211761 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma. Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187 [TBL] [Abstract][Full Text] [Related]
12. Quercetin inhibited the proliferation and invasion of hepatoblastoma cells through facilitating SIRT6-medicated FZD4 silence. Liu T; Li Z; Tian F Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S96-S107. PubMed ID: 34219513 [TBL] [Abstract][Full Text] [Related]
13. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480 [TBL] [Abstract][Full Text] [Related]
14. IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma. Li L; Wu Y; Huang HT; Yong JK; Lv Z; Zhou Y; Xiang X; Zhao J; Xi Z; Feng H; Xia Q J Cancer Res Clin Oncol; 2024 Aug; 150(8):377. PubMed ID: 39085725 [TBL] [Abstract][Full Text] [Related]
15. Intracellular localization of beta-catenin expression plays a possible prognostic role on the outcome of hepatoblastoma patients. Celtik U; Dokumcu Z; Divarci E; Guler E; Ataseven E; Nart D; Yilmaz F; Celik A; Ergün O Pediatr Surg Int; 2020 Jul; 36(7):817-825. PubMed ID: 32436062 [TBL] [Abstract][Full Text] [Related]
16. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice. Zhang W; Meyfeldt J; Wang H; Kulkarni S; Lu J; Mandel JA; Marburger B; Liu Y; Gorka JE; Ranganathan S; Prochownik EV J Biol Chem; 2019 Nov; 294(46):17524-17542. PubMed ID: 31597698 [TBL] [Abstract][Full Text] [Related]
17. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605 [TBL] [Abstract][Full Text] [Related]
18. LncRNA OIP5-AS1 aggravates the stemness of hepatoblastoma through recruiting PTBP1 to increase the stability of β-catenin. Jiang W; Ou ZL; Zhu Q; Yao YB; Zai HY Pathol Res Pract; 2022 Apr; 232():153829. PubMed ID: 35255389 [TBL] [Abstract][Full Text] [Related]
19. The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans. Zhang S; Zhang J; Evert K; Li X; Liu P; Kiss A; Schaff Z; Ament C; Zhang Y; Serra M; Evert M; Chen N; Xu F; Chen X; Tao J; Calvisi DF; Cigliano A Am J Pathol; 2020 Jul; 190(7):1397-1413. PubMed ID: 32283103 [TBL] [Abstract][Full Text] [Related]
20. Upregulated YAP promotes oncogenic CTNNB1 expression contributing to molecular pathology of hepatoblastoma. Lu S; Jiang M; Chen Q; Luo X; Cao Z; Huang H; Zheng M; Du J Pediatr Blood Cancer; 2022 Sep; 69(9):e29705. PubMed ID: 35404538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]